Investigation of hFVIII production in mammary glands of transgenic mice

Monoclon Antib Immunodiagn Immunother. 2014 Oct;33(5):325-9. doi: 10.1089/mab.2014.0008.

Abstract

Hemophilia A is an X-linked disorder affecting 1 in 10,000 males. The disease is caused by a defect or mutation of factor 8 or 9. Human factor 8 gene (hFVIII) is a relatively large gene consisting of 26 exons and approximately 2,351 amino acids with a length of 9 Kb mRNA. Expression of hFVIII in mammalian milk is becoming a widespread strategy for high-level production of hFVIII because of the most complex post-translational modifications. The aim of this study was the cloning and expression of hFVIII in mammary glands of two transgenic mice. To obtain a recombinant plasmid, first a plasmid carrying an FVIII gene fragment (pCMV6-hFVIII) was digested by EcoRI-SalI restriction enzymes and then the fragment was purified from agarose gel and inserted into a pUCWAP7 vector carrying a tissue-specific promoter (mWAP 4.1 kbp). After that, it was isolated by agarose gel and transferred into the murine zygotes by standard microinjection methods. Methods for expression of recombinant FVIII RT-PCR and ELISA were studied. The results show the successful expression of factor FVIII gene and its product in the mouse mammary glands.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Factor VIII / genetics*
  • Factor VIII / metabolism*
  • Gene Expression / genetics
  • Genetic Vectors / genetics
  • Hemophilia A / genetics
  • Hemophilia A / metabolism
  • Humans
  • Mammary Glands, Animal / metabolism*
  • Mice
  • Mice, Inbred BALB C
  • Mice, Transgenic / genetics*
  • Milk / metabolism
  • Plasmids / genetics
  • Promoter Regions, Genetic / genetics

Substances

  • Factor VIII